15 July 2021

CeBIL Faculty's paper on Patent Waiver, Compulsory Licensing and COVID-19

Recent months have seen intensified global calls for an intellectual property waiver of COVID-19 related vaccines, treatments and related products. CeBIL Faculty Behrang Kianzad and Jakob Wested revisit the arguments pro and against patent waiver and compulsory licensing in their latest contribution to European Pharmaceutical Law Review, found here: